Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to publicise the availability of semaglutide injections for the prevention of heart attacks and strokes among eligible patients with cardiovascular disease, following the publication of guidance from NICE and the planned rollout of the treatment by NHS England.

NHS England publicly announced the planned rollout and eligibility criteria for semaglutide for cardiovascular risk reduction, which are available on the NHS.UK website, and has supported implementation through national commercial and financial arrangements. NHS England does not currently hold a validated national estimate of the number of patients who have commenced treatment specifically under this indication, or of the implementation status for every general practice or integrated care board.